Huntington's disease (HD) is an inherited neurodegenerative disorder caused by abnormal expansion of CAG repeats in the gene encoding huntingtin. Mutant huntingtin undergoes proteolytic processing and its N-terminal fragment containing polyglutamine repeat accumulates as inclusion not only in nucleus but also in cytoplasm and neuronal processes.
INTRODUCTION
Huntington's disease (HD) is an autosomal-dominant progressive neurodegenerative disorder, which is characterized by motor, cognitive and psychiatric disturbances (1) (2) (3) . HD is caused by CAG repeat expansion in the gene encoding for protein huntingtin (4). The disease falls under the category of polyglutamine (polyQ) disorders that includes spinal and bulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA), and several spinocerebellar ataxias (SCAs) (1, (5) (6) (7) (8) . Presence of intra-nuclear inclusions of mutant huntingtin and selective neurodegeneration of specific brain regions are the characteristic pathological features of HD (9-12). Full-length mutant huntingtin cleaved by specific proteases and its N-terminal region containing polyQ repeats rapidly misfolded and accumulated as inclusion bodies (10, (13) (14) (15) . These inclusions sequester essential component of chaperones and ubiquitin-proteasome system (UPS) contributing to impaired cellular protein quality control system and eventually neurodegeneration (16) (17) (18) (19) (20) (21) (22) .
Multiple approaches have been pursued to understand and regulate the progression of HD. One such strategy has been to study the role of UPS and autophagy in the clearance of mutant huntingtin and pathogenesis of HD (21, (23) (24) (25) . This is based on the fact that mutant huntingtin and its aggregates are ubiquitinated, a pre-requisite step for a misfolded protein to be cleared not only by proteasome but also through autophagy (26, 27) . In fact, multiple evidences now indicate that mutant huntingtin and its aggregates can be degraded by proteasome and autophagic machinery (20, 21, 28) . Ubiquitin ligase (E3 enzyme) is the crucial component of UPS because of its substrate recognition property and existence as large diversities(26). There is a growing body of evidence suggesting their ability to slow down polyQ-induced disease pathogenesis. CHIP, a chaperone-dependent E3 ubiquitin ligase, has been shown to ubiquitinate and degrade polyQ proteins and reduce its associated toxicity in mice and a zebra fish model of HD (29, 30) . Its over-expression has also been shown to have Recently we have demonstrated function of Ube3a (also known as E6-AP) as a protein quality control ubiquitin ligase and its involvement in clearance of misfolded polyQ proteins(36, 37). Ube3a has also been seen to recruit to aggregates and its soluble levels depleted in several brain regions of R6/2 mice model of HD, indicating its possible involvement in disease progression (38) . Its deficiency has previously been shown to intensify SCA1 pathology by specifically degenerating Purkinje cells layer with surprising concomitant reduction of aggregates (39). Although the level of Ube3a is reduced globally and its role is suggested in HD, there is no direct evidence to implicate its involvement in HD pathogenesis (38, 40) . Furthermore, how its deficiency decrease aggregates in Purkinje cells is not clear. Ube3a gene is paternally imprinted in the brain particularly in neurons (41) (42) (43) and loss of function of maternally inherited Ube3a causes Angelman syndrome (AS), a neurodevelopmental disorder characterised by cognitive and motor deficits (44, 45) . Ube3a-maternal deficient mice (model mice for AS) also recapitulate many essential features of AS including learning and memory impairment along with motor and other behavioural abnormalities (46, 47) . In the present study, we used the feature of preferential expression of maternal Ube3a gene to generate Ube3a-maternal deficient HD mice (that will not express Ube3a specifically in the brain) in order to better understand the role of Ube3a in HD progression. These Ube3a-maternal deficient HD mice demonstrates an overall accelerated disease phenotype, evidenced by higher neuronal aggregates load, worsening of motor behavioural performance and finally increased mortality rate in comparison with HD.
RESULTS

Absence of Ube3a in HD mice brain results in reduced body weight and shorter lifespan
Ube3a has been shown to promote the clearance of mutant huntingtin, recruits to mutant huntingtin aggregates and its level is decreased in the brain of symptomatic R6/2 HD mice (36-38). To understand the precise role of Ube3a in the clearance of mutant huntingtin and disease progression, we generated brain Ube3a-deficient R6/2 HD mice by crossing male R6/2 HD with Ube3a-maternal deficient heterozygous female (AS model mice). It is important to note that Ube3a-maternal deficient heterozygous mice will not express Ube3a gene in their neurons because paternally inherited Ube3a gene is imprinted in the neuron (41) (42) (43) . Mice thus generated were genotyped and categorized as wild type, Ube3a-maternal deficient, HD and Ube3a-maternal deficient HD (Fig.1A) . Immunoblot analysis of IC2 (detects extended polyQ tract) and Ube3a in the cortical lysates further confirmed the specified genotypes (Fig.1A, bottom panel) . Interestingly, we noticed lifespan of Ube3a-maternal deficient HD mice were reduced to almost half in comparison with HD mice (Fig.1B) . While HD mice survived up to 100-115 days, double-mutants started dying as early as 40 days and survived not longer than 60-65 days of age. Ube3a-maternal deficient mice survived normally similar like wild type. All four genotypes appeared to be phenotypically similar till the age of 4 weeks. From the age of 5-6 weeks, HD and Ube3a-maternal deficient HD mice showed decrease in body weight compared to wild type and Ube3a-maternal deficient mice (Fig.1C) . Double mutant mice exhibited significant differences in body weight from 6 weeks onwards compared to HD. 
Loss of Ube3a in HD mice brain accelerates behavioral abnormalities
We next compared the disease progression between HD and Ube3a-maternal deficient HD mice. All four age-matched genotypes obtained were tested for a battery of motor tests and aspects of locomotion from 4 weeks of age. Gait abnormalities were tested by analyzing footprint pattern, while mice walked on a narrow straight trail. HD and Ube3a-maternal deficient HD mice began to display unevenly spaced, non-uniform gait with statistically shorter stride length from 6 weeks onwards ( Fig.2A) . However, at 7 weeks of age, Ube3a-maternal deficient HD mice exhibited significantly shorter stride length compared to HD ( Fig.2A) . The stride length of AS mice was not statistically different from the wild type group up to 7 weeks of age. Motor co-ordination was assessed by allowing these mice to perform on rotating rod at a constant speed of 10 rpm. At 4 weeks of age, Ube3a-maternal deficient HD mice showed significant difference in rotarod performance compared to HD and became worse over time (Fig.2B) . HD mice were performing equally well like wild type and AS mice at 4 weeks of age, but their performance starts deteriorating from 5-6 weeks onwards. The rotarod performance of AS mice was very similar to wild type in this experimental setup, however, significant difference can be observed at higher speed of roratod. When suspended from tail, Ube3a-maternal deficient HD mice mostly clasped their hind and forelimbs firmly at 5 weeks of age with increasing severity over time (Fig.2C) . HD mice at 5-7 weeks of age showed only intermittent hind limbs clasping, while AS mice in these age did not exhibit any sign of clasping. It is important to note that AS mice has been shown to exhibit hind limbs clasping at 7-8 months old age (48) . The proportion of Ube3a-maternal deficient HD mice that showed clasping was always higher than that of HD mice during 5-7 weeks of age (Fig.2D) . To further compare fine motor co-ordination and balance, mice were assessed on their ability to traverse a narrow beam. Up to 7 weeks of age, all genotypes were able to traverse the beam with equal ease except Ube3a-maternal deficient 7 HD mice, which took much longer time to traverse the beam and made frequent hind-limb slips ( Fig.2E and F) . These double mutant mice also manifested increasing incidence of seizure particularly during advanced stage of disease progression (6-8 weeks of age). During behavioral studies, many double mutant mice (about 20-30% at 7 weeks of age) died because of seizures and this could be due to handling. Therefore mice used for survival studies were not allowed to perform behavioral tests. AS or HD mice at this age did not exhibit seizures during behavioral studies.
Reduced brain weight, accelerated striatal atrophy accompanied by altered histopathology upon loss of Ube3a in HD mice
Reduced striatal volume due to severe atrophy and reduced total brain weight is the characteristic feature of HD neuropathology. In R6/2 model of HD mice, decrease in brain weight and striatal volume is clearly observed from 8-10 weeks onwards. After sacrificing the animals at 8 weeks of age, total brain weights were measured and found to be significantly reduced in Ube3a-maternal deficient HD mice in comparison with HD and other mice group (Fig.3A) . Although AS and HD mice showed reduced brain weight compared to wild type control it was not statistically significant. To determine the extent of striatal atrophy, stereological evaluation of striatal volume using Nissl-stained sections of 8 weeks old animals was done. Striatal volume of Ube3a-maternal deficient HD mice was found to be significantly lower than that of HD and other mice group ( Fig.3B and C) . HD mice at this age also exhibited reduced striatal volume compared to wild type or AS mice but the decrease were not statistically significant, which could be because of early stage of detecting these alterations.
Although, average brain weight of Ube3a-maternal deficient HD mice was much lower than HD mice, there was no detectable loss of neurons, changes in cell body S1 ). We did not observe any sign of microgliosis in the striatum and cortex of Ube3a-maternal deficient HD brain as checked by immunostaining of Iba1, a microglial marker ( Supplementary Fig.S2A ). We also checked for induction of various cytokines by cytokine bead array (CBA) and found no gross change in principle cytokines between HD and Ube3a-maternal deficient HD mice striatum ( Supplementary Fig.S2B ). However, cortical dendritic projections of Ube3a-maternal deficient HD mice brain appeared to be abnormally shorter compared to same age group (8 weeks) HD mice (Fig.3D ). This was confirmed by using different neuronal markers, which stain neurofilaments (detected by SMI32), cytoskeleton components (detected by -III tubulin or Tuj-1), microtubules (detected by microtubuleassociated protein 2 or MAP2) and neuronal nuclei (detected by NeuN). The cortical dendritic projections of AS mice brain were also slightly shorter when compared to wild type or HD mice ( Supplementary Fig.S3 ).
Increased load of huntingtin aggregates upon loss of Ube3a in HD mice brain
We next compared distribution and frequency of mutant huntingtin aggregates in agematched HD versus Ube3a-maternal deficient HD mice using huntingtin-specific antibody.
This huntingtin antibody (Santa Cruz, SC-8767) was generated against N-terminal region of human huntingtin and detects both human and mouse huntingtin. At 8 weeks of age, Ube3a-maternal deficient HD mice brain showed profuse aggregation across all brain regions ( Fig.4 and Supplementary Fig.S4 ). HD mice brain at the same age exhibited comparatively reduced number of aggregates but strong diffused expression of mutant huntingtin. When these huntingitin-positive aggregates were double-labeled with ubiquitin antibody, most huntingtinpositive aggregates were also strongly stained with ubiquitin in HD but not in Ube3a-maternal deficient HD mice brain. Many huntingtin-positive aggregates in Ube3a-maternal 9 deficient HD brain were devoid of or very weakly stained with ubiquitin (indicated by arrow in Fig.4 and also shown in zoomed images). Immunostaining pattern of either huntingtin or ubiquitin in AS mice brain was very similar to wild type ( Supplementary Fig.S5 ).
Approximate numbers of huntingtin-positive aggregates were then counted across different brain regions (motor cortex, striatum, hippocampus and Purkinje cells layer of cerebellum). Frequency of huntingtin-positive aggregates was found to be significantly higher across all regions in Ube3a-maternal deficient HD mice brain compared to HD (Fig.   5A ). We next compared the ratios of huntingtin and ubiquitin-positive aggregates in different brain regions of 8 and 12 weeks old HD and 8 weeks old Ube3a-maternal deficient HD mice brain after double immunofluorescence staining of brain sections using huntingtin and ubiquitin antibodies. The ratio of ubiquitin to huntingtin-positive aggregates was nearly similar in various brain regions of HD mice at different ages. In contrary, the ratio was significantly reduced in case of Ube3a-maternal deficient HD mice brain (Fig.5B) .
Approximately, 95% of huntingtin aggregates were positive for ubiquitin in cortical, hippocampal and striatal region of HD mice that was reduced to about 70% in Ube3a-maternal deficient HD mice. Although, Purkinje cells in Ube3a-maternal deficient HD mice did not show significant difference in the ratio of ubiquitin to huntingtin aggregates, the aggregates in these cells were less intensely labeled with ubiquitin compared to huntingtin.
These findings strongly imply significant contribution of Ube3a in the ubiquitination of mutant huntingtin.
Severe depletion of DARPP-32 levels in the striatum of Ube3a-maternal deficient HD mice brain Selective degeneration of striatal medium spiny neurons (MSNs) is another major pathological feature of HD. Since we did not find any gross neuronal cell loss in striatum of Ube3a-maternal deficient HD mice brain, we further explore possible dysfunction of MSNs.
We first analyzed total DARPP-32 level (a dopamine-regulated phoshpho protein marker for MSN activity) since its altered expression is reported in HD mice brain (49) . As expected, DARPP-32 staining was reduced in striatal sections obtained from HD mice in comparison with wild type or Ube3a-maternal deficient brain at 8 weeks of age. The reduction was much more dramatic in the striatum of Ube3a-maternal deficient HD mice when compared to HD (Fig.6A) . The same was re-confirmed through immunoblot analysis of DARPP-32 ( Fig.6B and C). Interestingly, we also observed a significant reduction of DARPP-32 in Ube3a-maternal deficient mice striatum, indicating that the drastic reduction of this protein in Ube3a-maternal deficient HD striatum could be due to additive effect. In contrast, levels of GAD65/67 (general marker for GABAergic neurons) were indistinguishable among all genotypes confirming specific defect in dopaminergic-signaling of MSNs (Fig.6D) . Figure   6E showed the significant reduction of Ube3a protein in the cortex and striatum of HD mice compared to wild type control at 8 weeks of age. Similar reduction of Ube3a was also observed in the hippocampus of HD mice ( Supplementary Fig.S6 ).
Discussion
In this work we have highlighted ubiquitin ligase Ube3a as an important mediator of HD progression. By creating a HD model that selectively lacked Ube3a in the brain, we report severe acceleration of disease phenotype contributing to early death of these mice. Removal of Ube3a from the HD mice brain also resulted significant global increase in aggregates load in comparison with HD mice.
The findings presented here are in agreement with some of our earlier observations that indicate Ube3a function as cellular protein quality control ubiquitin ligase and promote clearance of misfolded polyQ proteins including mutant huntingtin(36, 37). Ube3a also recruits to mutant huntingtin aggregates and its soluble level was found to be progressively decreased in HD mice brain indicating further the critical role of Ube3a in disease progression(38). Here we have also found that the reduction in endogenous Ube3a in HD mice can be seen as early as 8 weeks of age. Ube3a dysfunction is linked with AS (41, 44, 45 ) and its mice model exhibits many crucial features of AS including cognitive, motor and other behavioural abnormalities (46, 47) . Thus loss of function of Ube3a in HD mice could not only increase the global aggregate load and associated pathology but also might be directly connected with progressive cognitive and motor abnormalities observed in HD.
An earlier studies have linked lack of Ube3a to increased SCA1 pathology along with a surprising reduction in ataxin-1 aggregates in Purkinje cells, opposing the role of aggregates in the disease pathology (39). We instead demonstrated a significant increase in aggregates frequency along with an overall increased HD pathology and therefore could favour the idea of the role of aggregates in disease pathogenesis (50) (51) (52) . The discrepancy in aggregation profile between two polyQ disease models is somewhat perplexing and needs further investigation. The biochemical nature of huntingtin and ataxin-1, their size and length of polyQ repeats, their affinity towards Ube3a as well as in the cell they are expressed could be the determining factor for the discrepancies. The increased disease severity in Ube3a-deficient HD or SCA1 models could be due to some targets of Ube3a that is also affected in response to polyQ protein or their aggregates. For example, p53 has been shown as a target of Ube3a (46) and its levels also up-regulated in HD mice brain (53) . DARPP-32 could be another potential common target leading severe dysfunction of striatal MSN function and this abnormality could be very specific to HD. Interestingly, we also observed a significant reduction in the ubiquitination of huntingtin aggregates in Ube3a-maternal deficient HD brains compared to HD. The phenotypic traits of 6-8 weeks old Ube3a-deficient HD mice were observed to be very similar to 12-14 week old HD mice, indicating an accelerated disease progression. We saw increased mortality rate, decreased total body and brain weight in these mice. This was accompanied by severe atrophy of the striatum and enlarged ventricles. To our surprise, we did not observe any overt neuronal death in these areas but their dendritic projections were degenerated. Also the expression of DARPP-32, which is essential to maintain dopamine signalling in MSN of striatum (54) , was found to be severely reduced in double-mutant mice.
Its level is known to be reduced even in pre-symptomatic R6/2 HD mice and has been linked to striatal dysfunction (49) . We found an even further reduction of DARPP-32 in Ube3a-maternal deficient HD mice suggesting accelerated MSN dysfunction. Our study also indicates that Ube3a could be an important regulator of DARPP-32 and MSN function as the level of Ube3a was progressively decreased along with DARPP-32 in the striatum of HD mice. In fact, dysfunction of nigrostriatal dopaminergic system has been reported in AS mice (48) .
Behavioural performance tasks, which require motor learning and coordination are tightly controlled by cortico-striatal circuitry were also impaired to a level much below agematched control HD mice. Cortical dendritic projections appeared shorter and fragmented in Ube3a-maternal deficient HD mice without any obvious neurodegenerartion. This stunting in Ube3a-deficient HD mice might have aggravated due to lack of Ube3a. Because Ube3a is required for the specification of the apical dendrites and dendrite polarization and Ube3a-maternal deficient mice exhibit reduced dendritic arborisation (55, 56). Overall, this severe Altogether, our studies provide strong evidence that Ube3a could play a crucial role in the progression of HD and therefore might be a potential therapeutic target to slow down the disease progression. Recently, topoisomerase inhibitors have been shown to unsilence the dormant paternal Ube3a in the brain (57) . Restoration of Ube3a functions in the brain, by the use of such drugs, might provide promising reversal of the HD pathology.
MATERIALS AND METHODS
Materials
Goat polyclonal anti-huntingtin and rabbit polyclonal anti-Ube3a were purchased from Santa Cruz Biotechnology, rabbit polyclonal anti-ubiquitin was from DAKO, mouse monoclonal anti-SMI32 was from Covance, rabbit polyclonal anti--tubulin (Tuj-1) and anti--actin were from Sigma, rabbit polyclonal anti-MAP2 was from Cell signalling and mouse monoclonal NeuN, 1C2 and rabbit polyclonal anti-GAD were purchased from Millipore, Rabbit polyclonal anti-DARPP-32 was from Abcam. Donkey anti-goat, anti-rabbit or anti-mouse alexa fluor (AF)-594 and donkey antirabbit or anti-mouse AF-488 were purchased from Molecular Probes. AP-and HRP-conjugated anti-mouse, anti-rabbit IgG, ABC kit, ImmPACT Novared Peroxidase Substrate and vectashield mounting media with DAPI were purchased from Vector Laboratories. PCR reagents were obtained from TaKaRa Biomedical and Tunel assay kit was from Promega.
Animals
Ovarian-transplanted hemizygous female mice carrying the HD exon 1 gene with ~150 CAG repeats (strain B6CBA-Tg (HDexon1) 62Gpb/3J) was purchased from The Jackson Laboratory and crossed with B6CBAF1/J males. Genotyping was carried out using PCR as described previously (58) . Heterozygous Ube3a mice were also obtained from the Jackson Laboratory (strain 129-Ube3atm1Alb/J) and maintained in the C57BL/6 background.
Genotyping was carried out as described (46) . HD transgenic males were crossed with maternally Ube3a-deficient females, to obtain Ube3a-intact HD and Ube3a-deficient HD mice along with Ube3a-deficient and Ube3a intact control mice. These mixed background mice were used in all experiments. Animals had free access to a pelleted diet and water ad libitum. Mice were either sacrificed by cervical dislocation and brain parts were stored at -80°C or anesthetised and transcardially perfused with PBS containing 4% PFA (w/v). All animal experiments were performed according to the protocol approved by the Institutional Animal Ethics Committee of the National Brain Research Centre.
Survival study
Mice were assessed for viability from age of 4 weeks twice daily. Mice used for this study did not undergo behavioural assessment, to rule any affect of them on death of animals.
Survival data was analysed by Kaplan-Meier survival analysis and multiple curves were compared by log rank test.
Behavioural tests
Gait analysis
For foot-print gait analysis, the fore and hind paws of the mice were dipped in blue and red nontoxic paints respectively. Mice were placed at an open end of a wooden tunnel (40 cm×5 cm) lined with paper. The mice were trained for 3 days to walk through the tunnel and then tested for three trials per week. Two to four steps from the middle portion of each run were measured for hind-stride length and hind-base width.
Rotarod test
Mice were placed on the rotarod (Scientific Instruments, New Delhi) and were taught to stay on the rod which was rotating with a constant speed of 5 rpm. Mice that would fall were repeatedly placed back on the rod until they were able to stay on the rotarod for at least 30 sec. Mice were trained for 3 days and then tested for 5 trials per week (each trial comprised of 3 sessions of 60 sec) at a constant rod speed of 10 rpm. Sessions of all 5 trials in each week were averaged to calculate the overall time for each mouse with a maximum possible score of 60 sec. Data were expressed as % total time in rotarod.
Clasping behaviour
Mice were suspended with their tails for 60 sec for 2 trials per session and the proportion of mice that clasped by firmly bringing their all four limbs together was evaluated. Clasping scores were allotted to each mouse in every session as, 0 if no clasping is observed, 1 if abnormal extension of the hind limbs was noticed, 2 if mouse is starting to clasp, and 3 if clasping is strongly established. All tests were performed in a blinded fashion.
Beam walk test
Mice were allowed to walk and cross an 80 cm long and 20 mm wide beam which was at a height of 50 cm from ground. Mice were trained for 3 days and during that time all mice learned to cross the beam and reach dark box kept on the other end. Mice were tested for three trials per day. Total amount of time taken and number of slips made while crossing the beam by each mouse was calculated from the video recordings made during experiments.
Measurement of striatal volume
Mice were perfused with 4% paraformaldehyde and brains were carefully removed. Coronal cryosections (20 m) were performed and then processed for Nissl staining. The stereological volume of striatum was calculated in arbitrary sections of a systematic set (e.g. every 5 th section with the first section selected randomly among first five sections) from the front of the striatum to levels slightly posterior to the level of the crossing of the anterior commissure (59) . The perimeter of the striatum was traced in each of the sections using 1x Nissl stained images in the NeuroLucida software. Subsequently, total striatal volume was calculated as described (60) .
Immunostaining and aggregates counting
Paraformaldehyde fixed brains were processed for cryo-sectioning to obtain 20 µm thick sections. Sections were then processed for immunostaining using reagents from Vector Laboratories as described earlier (61) . Briefly, after antigen retrieval of 45 min at 70°C, sections were blocked and probed using various primary antibodies. Huntingtin, ubiquitin, and DARPP-32 antibodies were used at 1:1000, 1:200 and 1:200 dilutions respectively.
Biotinylated secondary antibodies were used at a dilution of 1:500 and signal was enhanced using ABC kit and developed using ImmPACT Novared Peroxidase Substrate. Stained sections were imaged using a Leica DM RXA2 microscope. 
Cytokine bead array and Tunel staining
Cytokine bead array (CBA, mouse inflammation kit, BD Biosciences) was used to quantitatively measure the inflammatory cytokines expression in the striatal samples obtained from all 4 genotyped mice at 8 weeks old age. The assay was performed according to the manufacturer instruction using FACS calibur (BD Biosciences) and data was analyzed using CBA software. Tunel assay was done using Tunel assay kit as per manufacturer instruction.
Statistical analysis
Statistical analysis was performed using SigmaStat software. Values were expressed as mean ± SEM. Datas were analyzed by using one or two-way ANOVA followed by Holm-Sidak post-hoc test. Log rank test was used to analyze survival data. In some experiments, twotailed Student's t test was used for inter group comparison. P<0.05 was considered statistical significant. Inset shows 3X magnified images around an arrow marked by white area. Five mice in each group were analysed and 3 sections from each mouse were stained for immunostaining.
Section from different mice were placed on the same slide and processed for immunostaining.
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